medical research – The Milli Chronicle

Friday, May 1, 2026

Latest:

Banksy Unveils New London Sculpture of Flag-Bearing Figure in Westminster
From Prison Cell to Fitness Empire: How One New York Gym Became a Lifeline After Incarceration
Immunotherapy Reshapes Cancer Care as New Trials Deliver Surgery-Free Remission
Australia Eliminates Trachoma, Ending Infectious Blindness Threat After Decades of Indigenous Health Efforts
UNESCO Expands Heritage Protection in Island Nations as Climate Risks Threaten Traditional Knowledge

Factual Version of a Story

Featured Top Stories

NewsDesk MC May 1, 2026 Cancer Remission, Cancer Research, Cancer Treatment, CAR T Cell Therapy, clinical trials, Colon Cancer, Dostarlimab, Francis Crick Institute, Immune Checkpoint Inhibitors, immunotherapy, Jennifer Wargo, Karen Knudsen, MD Anderson Cancer Center, medical research, Memorial Sloan Kettering, Oesophageal Cancer, oncology, Oncology Innovation, Parker Institute, Personalized Medicine, Samra Turajlic, Sandra Demaria, Tumour Biology, Weill Cornell Medical Center

Immunotherapy Reshapes Cancer Care as New Trials Deliver Surgery-Free Remission

“We’re no longer only treating the tumour — in many cases, we are learning how to help the immune system

Featured News World

NewsDesk MC November 4, 2025 Center for Drug Evaluation and Research, clinical trials, drug approval process, drug safety, ethical governance, FDA ethics, FDA leadership change, FDA modernization, FDA reform, Food and Drug Administration, global drug safety, health policy, healthcare transparency, medical innovation, medical research, pharmaceutical innovation, pharmaceutical regulation, public health, Robert F. Kennedy Jr., U.S. health agencies, US FDA

US FDA’s Drug Division Undergoes Leadership Transition to Strengthen Integrity and Innovation

The U.S. Food and Drug Administration begins a new chapter in its drug evaluation and research division, focusing on ethics,

Featured Health Lifestyle

NewsDesk MC October 10, 2025 biotech mergers 2025, biotechnology acquisition, drug development news, global biotech investments, healthcare innovation, J&J biotech expansion, J&J pharma growth, Janssen Biotech collaboration, Johnson & Johnson acquisition, Johnson & Johnson news, Johnson & Johnson strategy., medical research, peptide-based drugs, pharmaceutical innovation, polycythemia vera treatment, Protagonist stock surge, Protagonist Therapeutics, rare disease therapy, Rusfertide PTG-300, WSJ report

Johnson & Johnson Eyes Major Leap in Biotech: Talks Underway to Acquire Protagonist Therapeutics in Billion-Dollar Move

In a bold bid to expand its cutting-edge drug pipeline, Johnson & Johnson is reportedly in advanced talks to acquire